Open Day 1 of ESOC 2025 in Helsinki: OPTIMIST Trial Highlights
European Stroke Organisation (ESO) has shared an insightful post on X:
”Missed it live? Revisit Day 1 PI insights from ESOC 2025 in Helsinki. Investigators, moderated by Jelle De Meester and Teresa Ullberg, discuss the OPTIMIST main trial – nearly 5,000 patients, 114 hospitals, 8 countries.”
Watch the footage here.
Day 1 of ESOC 2025 in Helsinki featured key insights from the highly anticipated OPTIMIST main trial.
The trial was presented by principal investigators and moderated by Jelle De Meester and Teresa Ullberg.
The large-scale trial enrolled nearly 5,000 patients across 114 hospitals in 8 countries, offering robust data on stroke care optimization.
For those who missed the live session, the discussion provided critical updates on trial methodology, patient outcomes, and future directions in acute stroke management.
A must-watch for clinicians and researchers shaping the next generation of stroke care!
Hemostasis Today, your daily source of latest news on stroke management.
-
Jul 17, 2026, 04:28Redefining Thromboprophylaxis in Multiple Myeloma: Early VTE Emerges as the Critical Therapeutic Challenge
-
Jul 16, 2026, 20:25Ilham Benzidia: Leaving ISTH 2026 With New Ideas and New Collaborations
-
Jul 16, 2026, 20:23Eman Hassan: A Fantastic Platelets and Megakaryocytes Session at ISTH 2026
-
Jul 16, 2026, 20:22Sankara Nelson Noah II: Investigating the Temporal Dynamics of Platelet – Leukocyte Interactions in Early Sepsis
-
Jul 16, 2026, 20:20Joseph Pierre Aboumsallem: Paris Certainly Delivered This Week, and Not Just Because of the Heat
-
Jul 16, 2026, 19:53Louise St. Germain Bannon: The End of Congress, the Beginning of New Collaborations
-
Jul 16, 2026, 19:18Steve Humphreys: Learning From the Leading Experts at ISTH 2026
-
Jul 16, 2026, 19:02Kellie Machlus: Where Science Meets Friendship at ISTH 2026
-
Jul 16, 2026, 18:51Aaron Paul Kithcart: When Clinical Research Comes Together at ISTH 2026